Analyst	Recommendation	Action	Price target	Projected	Date
Damon Delmonte KBW	Buy	Maintained	$21.00	+36.7%	07/23/2026
Crispin Love Piper Sandler	Buy	Maintained	$22.00	+43.2%	07/22/2026
Christopher Marinac Brean Capital	Hold	Initiated	$20.25	+31.8%	04/22/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	63.53M	65.75M	63.86M	64.11M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	29.04M	27.70M	28.84M	29.65M
Operating expense	34.36M	33.78M	34.44M	35.22M
Total operating expenses	34.36M	33.78M	34.44M	35.22M
Operating income	29.17M	31.97M	29.43M	28.89M
Other non operating income	-	-	-	-
EBT including unusual items	29.17M	31.97M	29.43M	28.89M
EBT excluding unusual items	29.17M	31.97M	29.43M	28.89M
Income tax expense	7.00M	8.33M	7.27M	7.14M
Effective tax rate	24.00%	26.04%	24.72%	24.72%
Other operating expenses	5.32M	6.08M	5.60M	5.57M
Net income	22.17M	23.64M	22.15M	21.75M
Net profit margin	34.90%	35.96%	34.69%	33.92%
Earnings per share	0.57	0.52	0.62	0.60
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-21.24M	-18.30M	-16.55M	-17.17M

Ask anything